Notable examples include the National Heart Failure (HF) Program established in Lithuania and the National Cardiological Network (KSK) recently initiated after a pilot phase in Poland (25), as well as the full reimbursement of medical (including angiotensin receptor-neprilysin inhibitor (ARNI) and SGLT2-inhibitors), devices, interventional, and surgical treatment of HF in Romania. The gene discussed is SLC5A2; the disease is hydrops fetalis.